Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.
Authors:
- S HodgsonSHS Hodgson
- H GriffithsHGH Griffiths
- H M ChapelHCH M Chapel
- E R MoxonEME R Moxon
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford regionThe Lancet, 1992
- Design a clinical information system.BMJ, 1992
- Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.Archives of Disease in Childhood, 1992
- Epidemiology of Haemophilus influenzae type b invasive disease in Wales.BMJ, 1991
- SAFETY AND IMMUNOLOGICAL RESPONSE TO HAEMOPHILUS-INFLUENZAE TYPE-B OLIGOSACCHARIDE-CRM197 CONJUGATE VACCINE IN 1-MONTH-OLD TO 6-MONTH-OLD INFANTS1990
- Screening for cancer of the cervix in elderly womenThe Lancet, 1990
- Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.Archives of Disease in Childhood, 1989
- Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.BMJ, 1986
- SCREENING FOR CERVICAL INTRAEPITHELIAL NEOPLASIA IN DUNDEE AND ANGUS 1962-81 AND ITS RELATION WITH INVASIVE CERVICAL CANCERThe Lancet, 1985